X4 Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	69.63	55.7	99.22	121.72	81.79	78.71
Short-Term Investments	52.56	46.36	15	-	-	-
Cash & Short-Term Investments	122.19	102.06	114.22	121.72	81.79	78.71
Cash Growth	-9.47%	-10.64%	-6.16%	48.82%	3.91%	-37.62%
Accounts Receivable	0.89	1.07	-	-	-	-
Other Receivables	0.72	0.64	0.56	1.15	0.75	0.92
Total Trade Receivables	1.61	1.71	0.56	1.15	0.75	0.92
Inventory	4.08	2.82	-	-	-	-
Other Current Assets	4.93	5.59	7.3	5.81	5.34	3.68
Total Current Assets	132.81	112.18	122.08	128.68	87.88	83.31
Net Property, Plant & Equipment	1.99	4.84	6.4	8.33	10.22	9.2
Other Intangible Assets	9.44	10	-	-	-	-
Goodwill	17.35	17.35	17.35	17.35	17.35	27.11
Other Long-Term Assets	1.97	2.08	1.44	1.23	1.72	3.26
Total Assets	163.56	146.45	147.26	155.59	117.18	122.87
Accounts Payable	5.05	8.62	8.95	7.78	4.28	3.14
Accrued Expenses	16.66	23.01	12.82	12.03	7.87	8.02
Current Portion of Long-Term Debt	-	-	-	1.32	0.8	-
Current Portion of Leases	1.2	1.25	1.1	1.2	1.08	0.79
Unearned Revenue	0.59	-	-	-	-	-
Total Current Liabilities	23.51	32.88	22.86	22.32	14.02	11.95
Long-Term Debt	76.06	75.43	54.57	32.3	33.14	33.18
Long-Term Leases	0.1	1.41	2.61	3.6	4.78	4.48
Other Long-Term Liabilities	2.27	14.59	16.12	23.3	0.83	0.46
Total Long-Term Liabilities	78.43	91.42	73.3	59.21	38.74	38.12
Total Liabilities	101.94	124.3	96.16	81.54	52.76	50.07
Common Stock	0.03	0.01	0.17	0	0.03	0
Additional Paid-in Capital	632.34	537.62	528.96	450.79	347.37	267.08
Accumulated Other Comprehensive Income	-0.12	-0.12	-0.12	-0.12	-0.12	-0.12
Retained Earnings	-570.63	-515.36	-477.91	-376.74	-282.87	-194.18
Shareholders' Equity	61.62	22.15	51.1	73.93	64.41	72.78
Total Liabilities & Equity	163.56	146.45	147.26	155.59	117.18	122.87
Total Debt	77.36	78.09	58.28	38.42	39.79	38.45
Net Cash (Debt)	44.84	23.97	55.94	83.3	42	40.26
Net Cash Growth	87.02%	-57.14%	-32.85%	98.32%	4.33%	-61.02%
Net Cash Per Share	2.79	3.58	9.44	39.34	48.94	60.16
Book Value	61.62	22.15	51.1	73.93	64.41	72.78
Book Value Per Share	3.83	3.30	8.62	34.91	75.05	108.76
Tangible Book Value	34.83	-5.2	33.75	56.58	47.06	45.67
Tangible Book Value Per Share	2.17	-0.78	5.69	26.72	54.83	68.25

Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q